Introduction

The recent surge in seasonal influenza cases across China has led to an alarming spike in the demand for the antiviral medication baloxavir marboxil, commonly known as Xofluza. Health authorities are now issuing urgent warnings against the hoarding of this essential medication, particularly cautioning parents against administering it to children without professional medical advice.

Price Surge and Accessibility Concerns

Xofluza, which is approved for individuals aged five and older, has seen its market price escalate from the standard 222 yuan (approximately S$41) to over 300 yuan on various e-commerce platforms. This dramatic increase raises concerns about accessibility for those in need during peak flu season.

Current Influenza Situation in China

According to the latest figures released by the Chinese Centre for Disease Control and Prevention (CDC), influenza cases have soared since December 2024, with a notable increase in the positivity rate of flu-like symptoms rising by 6.2% during the week ending December 29, 2024. The CDC indicated that regions in northern China are experiencing more severe outbreaks, though overall influenza levels remain lower than last year.

Severe Outbreaks in Liaoning

Particularly alarming is the situation in Liaoning province, where the number of flu cases witnessed a staggering weekly growth rate of over 123% last month. Reports indicate that over 99% of positive flu cases in the country are attributed to the influenza A virus, with 99.7% of flu patients infected by this strain in the last week of December.

Comparison with Oseltamivir

Pharmacist Sun Boyang from Peking University People’s Hospital highlighted the advantages of Xofluza over the more commonly known drug, oseltamivir (Tamiflu). Unlike oseltamivir, which requires a five-day administration of two tablets daily, Xofluza simplifies treatment by only needing a single dose for the entire duration of illness.

Authorities' Warnings for Safe Use

With fears of a drug shortage prompting some parents to stockpile Xofluza, authorities stress that any antiviral treatment should begin with a hospital evaluation to ensure the safety and appropriateness of the medication for children. Both pregnant and lactating women are also advised to exercise caution.

Expert Advice on Timely Treatment

Experts like Dr. Wang Quan from Capital Medical University underscore the importance of prompt treatment, noting that antiviral medications yield the best results when administered within 48 hours following infection confirmation. He reminds parents to carefully consider dosages of antipyretic medications based on their child's age and weight.

Manufacturer's Assurance

Despite rising concerns, Roche, the sole supplier of Xofluza in China, has assured the public that it has ample supplies of the drug to meet demand during the flu season. The company emphasizes its commitment to maintaining sufficient inventory levels to prevent a shortage.

Conclusion

As China faces this annual health ordeal, staying informed and following medical advice has never been more crucial. The flu season is upon us, and knowing how to navigate it safely could protect you and your loved ones. Stay vigilant and consult healthcare professionals for guidance!